NT-23 * PHASE 1/2A STUDY OF GLUTATHIONE PEGYLATED LIPOSOMAL DOXORUBICIN (2B3-101) IN BREAST CANCER PATIENTS WITH BRAIN METASTASES (BCBM) OR RECURRENT HIGH GRADE GLIOMAS (HGG)Bojana Milojkovic Kerklaan, Dieta Brandsma, Patricia M.M.B. Soetekouw et al.|Neuro-Oncology|2014Cited by 14
P08.03 * 2B3-101, GLUTATHIONE PEGYLATED LIPOSOMAL DOXORUBICIN, IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMAS AND BREAST CANCER BRAIN METASTASESDieta Brandsma, Philippe Aftimos, Véronique Dièras et al.|Neuro-Oncology|2014Cited by 11
Abstract P6-16-04: Phase 1/2a study of glutathione PEGylated liposomal doxorubicin (2B3-101) in breast cancer patients with brain metastasesPhilippe Aftimos, Dieta Brandsma, Bojana Milojkovic-Kerklaan et al.|Cancer Research|2015Cited by 6
Phase I/IIA Study with CNS-Targeted Liposomal Doxorubicin (2B3-101) in Patients with Brain Metastases (BM) From Breast Cancer (BC) and Other Brain TumorsPhilippe Aftimos, Dieta Brandsma, Véronique Dièras et al.|Annals of Oncology|2014Cited by 4